Home > Boards > US OTC > Biotechs > BioLargo, Inc. (BLGO)

Revenue from product sales for the three and

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Clariske Member Profile
 
Followed By 37
Posts 3,526
Boards Moderated 0
Alias Born 10/26/11
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/24/2019 5:23:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/24/2019 5:15:19 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 6/12/2019 4:26:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 5:28:28 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 5/24/2019 3:57:42 PM
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) Edgar (US Regulatory) - 5/23/2019 4:36:23 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 5/21/2019 6:01:14 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 5/20/2019 2:41:04 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/15/2019 4:24:22 PM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 5/15/2019 3:47:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/1/2019 6:59:44 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/1/2019 6:59:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/1/2019 6:50:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/1/2019 6:49:06 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/1/2019 6:48:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/1/2019 6:35:04 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2019 4:56:14 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/23/2019 4:12:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2019 9:06:36 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/29/2019 4:32:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/8/2019 5:21:56 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 2/11/2019 6:07:51 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 1/29/2019 2:44:04 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 1/28/2019 5:27:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/23/2019 10:55:50 AM
Clariske   Thursday, 08/16/18 12:21:53 AM
Re: None
Post # of 455 
Revenue from product sales for the three and six months ended June 30, 2018 increased by 216% and 270%, respectively, compared with the three and six months ended June 30, 2017.
Total revenues for the first six months of 2018 was $589,767. With over $300,000 of revenue in the second quarter, and more than $500,000 for the first six months, the company believes it will exceed $1,000,000 annual revenue in 2018.
Since the first of the year, the company has reduced its debt obligations by approximately $5,8 million.
The company has submitted an application to list its common stock on NASDAQ, as management believes uplisting from the OTCQB will provide many benefits to the company and its stockholders.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist